Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02981914
Title Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation
Recruitment Recruiting
Gender both
Phase Phase 0
Variant Requirements No
Sponsors University of Chicago
Indications

myelodysplastic syndrome

acute myeloid leukemia

mature B-cell neoplasm

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.